Classification of amyloidosis by laser microdissection and mass spectrometry-based proteomic analysis in clinical biopsy specimens

Blood

Volumn 114, Issue 24, 2009, Pages 4957-4959

  Vrana, Julie A ^a   Gamez, Jeffrey D ^a   Madden, Benjamin J ^a   Theis, Jason D ^a   Bergen III, H Robert ^a   Dogan, Ahmet ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID;

AMYLOIDOSIS; ARTICLE; BIOPSY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GOLD STANDARD; HEART AMYLOIDOSIS; HUMAN; HUMAN TISSUE; LASER MICRODISSECTION; MALE; PRIORITY JOURNAL; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY; TISSUE TYPING; CLASSIFICATION; LASER; METHODOLOGY; MICRODISSECTION;

AMYLOIDOSIS; FEMALE; HUMANS; LASERS; MALE; MICRODISSECTION; PROTEOMICS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 73949091104     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-07-230722     Document Type: Article

References (21)

1. Merlini G, Bellotti V. Molecular mechanisms of amyloidosis. N Engl J Med. 2003;349(6):583-596
2. Westermark P, Benson MD, Buxbaum JN, et al. Amyloid: toward terminology clarification. Report from the Nomenclature Committee of the International Society of Amyloidosis. Amyloid. 2005; 12(1):1-4.
3. Magy-Bertrand N, Dupond JL, Mauny F, et al. Incidence of amyloidosis over 3 years: the AMYPRO study. Clin Exp Rheumatol. 2008;26(6): 1074-1078.
4. Gertz MA, Comenzo R, Falk RH, et al. Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): a consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis, Tours, France, 18-22 April 2004. Am J Hematol. 2005; 79(4):319-328
5. Holmgren G, Ericzon BG, Groth CG, et al. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis. Lancet. 1993;341(8853):1113-1116.
6. Stangou AJ, Hawkins PN. Liver transplantation in transthyretin-related familial amyloid polyneuropathy. Curr Opin Neurol. 2004;17(5):615-620.
7. Howie AJ, Brewer DB, Howell D, Jones AP. Physical basis of colors seen in Congo redstained amyloid in polarized light. Lab Invest. 2008;88(3):232-242.
8. Picken MM, Herrera GA. The burden of "sticky" amyloid: typing challenges. Arch Pathol Lab Med. 2007;131(6):850-851.
9. Picken MM. New insights into systemic amyloidosis: the importance of diagnosis of specific type. Curr Opin Nephrol Hypertens. 2007;16(3):196-203.
10. Solomon A, Murphy CL, Westermark P. Unreliability of immunohistochemistry for typing amyloid deposits. Arch Pathol Lab Med. 2008;132(1): 14; author reply 14-15.
11. Satoskar AA, Burdge K, Cowden DJ, et al. Typing of amyloidosis in renal biopsies: diagnostic pitfalls. Arch Pathol Lab Med. 2007;131(6):917-922.
12. Kebbel A, Rocken C. Immunohistochemical classification of amyloid in surgical pathology revisited. Am J Surg Pathol. 2006;30:673-683.
13. Murphy CL, Wang S, Williams T, Weiss DT, Solomon A. Characterization of systemic amyloid deposits by mass spectrometry. Methods Enzymol. 2006;412:48-62.
14. Murphy CL, Eulitz M, Hrncic R, et al. Chemical typing of amyloid protein contained in formalin-fixed paraffin-embedded biopsy specimens. Am J Clin Pathol. 2001;116(1):135-142.
15. Kaplan B, Martin BM, Livneh A, Pras M, Gallo GR. Biochemical subtyping of amyloid in formalin-fixed tissue samples confirms and supplements immunohistologic data. Am J Clin Pathol. 2004;121(6):794-800.
16. Tirzaman O, Wahner-Roedler DL, Malek RS, et al. Primary localized amyloidosis of the urinary bladder: a case series of 31 patients. Mayo Clin Proc. 2000;75(12):1264-1268.
17. Gertz MA, Merlini G, Treon SP. Amyloidosis and Waldenstrom's macroglobulinemia. Hematology Am Soc Hematol Educ Program. 2004;257-822.
18. Rodriguez FJ, Gamez JD, Vrana JA, et al. Immunoglobulin derived depositions in the nervous system: novel mass spectrometry application for protein characterization in formalin-fixed tissues. Lab Invest. 2008;88(10):1024-1037.
19. UniProt database. http://www.uniprot.org/. Accessed October 20, 2009.
20. Abraham RS, Geyer SM, Price-Troska TL, et al. Immunoglobulin light chain variable (V) region genes influence clinical presentation and outcome in light chain-associated amyloidosis (AL). Blood. 2003;101(10):3801-3808.
21. Dogan A, Zepeda VJ, Vrana JA, et al. Leukocyte chemotactic factor 2: a novel cause of renal and hepatic amyloidosis associated with nephrotic syndrome and chronic liver disease [abstract]. Lab Invest. 2009;89(suppl 1):302a. Abstract 1367.